SUMMARY EDTA plasma samples from 13 patients with ankylosing spondylitis (AS) were fractionated on Sephadex G-200 and the quantities of C3 and IgG within the first protein peak determined by a sensitive haemagglutination-inhibition assay. Seven patients with AS had C3 detectable in the first peak and this was associated with an increased concentration of IgG in the corresponding fraction. These 7 patients had more active disease but did not have more peripheral arthritis. Our results indicate that circulating immune complexes capable of initiating complement activation are present in the circulation of patients with ankylosing spondylitis.
Despite the striking association between ankylosing spondylitis (AS) and HLA B27 the role of immunological factors in the pathogenesis of the disease is not clear. Recently it has been proposed that AS may be related in some way to infection with Klebsiella pneuomoniae, a bacterium which may possess antigens cross-reacting with HLA B27.1
One way by which immune reactions may be involved in tissue damage in AS may be via the deposition of immune complexes. In a previous paper we presented evidence that immune complexes are present in the circulation of patients with this disease. The complexes were detected by the technique of inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC).2 However, these complexes may not be of pathological importance, since they may not activate the complement system. Complement activation is an important mechanism for the induction of inflammation. There is some evidence that activation does occur in AS, since raised serum levels of C3 and C4 inactivation products have been noted. The plasma concentration of C3 and C4 was within the normal for all 13 patients studied irrespective of whether they had active disease as judged by the ESR, duration of morning stiffness, or inflamed peripheral joints (results not shown).
MACROMOLECULAR c3 AND IgG
The elution characteristics of C3 and IgG for a control normal plasma chromatographed on Sephadex G-200 is shown in Fig. IA Table 2 are shown in summary form some of the clinical details for these 2 groups of spondylitic patients.
There is no difference in the duration of disease between them and the amount of inflammatory joint disease, though the group with more MMC3 have a more elevated ESR and more prolonged morning stiffness. Since none of the patients had uveitis, it was not possible to ascertain whether there is any relationship between this complication and the presence of immune complexes. group.bmj.com on October 13, 2017 -Published by http://ard.bmj.com/ Downloaded from This study shows that material containing IgG and MMC3 is found in EDTA-plasma samples of some 50% of patients with AS. One explanation for these findings is that they are due to circulating immune complexes. A similar proportion of patients were found to have circulating immune complexes by the inhibition of ADCC, a technique which does not depend on complement components.2 Chromatography on Sephadex G-200 revealed a wide range of molecular weights for such complexes, and this observation has been confirmed in this study.
Although the results are consistent with the idea that immune-complex-triggered activation of the complement system occurs in patients with AS, other explanations are possible. The raised ESR and more active disease in the positive group may be accompanied by high C3 and factor B levels (both are acute-phase proteins), which may potentiate the feedback mechanisms which give rise to C3 conversion. We believe that this is not the explanation for our findings, since 3 of the samples in the control group were obtained from patients who had undergone surgery 3-5 days previously and in whom rises of acute-phase proteins were present without the presence of MMC3.
Material behaving as immune complexes has been described as being present in the serum or plasma of patients by other investigators.3 910 Some of these methods have involved analysis of changes in the complement system. Gabay et al.11 found complexes by the '251-Clq binding test and C3d conversion product in AS patients who were seropositive for IgM rheumatoid factor. None of our patients had rheumatoid factor. Our results are certainly consistent with the idea that immune-complex-triggered activation of the complement system is occurring in patients with ankylosing spondylitis.
Further aspects of the role of immune complexes in AS are worthy of study: first, whether the presence of complexes can be used to predict disease relapse; secondly, the role of complexes in the pathogenesis of extraspinal disease manifestations such as arthritis and uveitis; finally the nature of any extraneous antigen composing these complexes and its relationship to postulated aetiological agents such as Klebsiella.
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